Bankless founder David Hoffman explained his reasons for liquidating his ETH holdings in a post on X.
Hoffman wrote: "I remain extremely optimistic about the Ethereum network and the entire ecosystem ------ Ethereum's architectural design exists to maximize the success probability of its applications, L2, and ecosystem. The 'fat-app' theory means that applications on Ethereum can capture the vast majority of transaction fee revenue; while the 'Rollup-centric' roadmap means that L2 can achieve profit margins of up to 97%.
However, for the asset ETH itself, I find it increasingly difficult to see it being repriced by the market on a structural level ------ whether upwards or downwards. Therefore, my selling of ETH is not because I am bearish on ETH, but because I believe the narrative of 'ETH is Money' has essentially played out. I hope to allocate my funds to other opportunities in the market that I see."
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.

Imagine two global giants racing to shape the future of digital money: Japan, the careful architect building a…

















Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.












Imagine two global giants racing to shape the future of digital money: Japan, the careful architect building a…